LOW-DOSE IMMUNE TOLERANCE INDUCTION WITH EMICIZUMAB PROPHYLAXIS IN HEMOPHILIA A PATIENTS WITH HIGH-TITER INHIBITORS: PRELIMINARY RESULTS FROM THE BRAZILIAN EXPERIENCE

Autor: C Costa-Lima, JO Frade-Guanaes, VB Faiotto, AP Francisco, NM Foschi, ALA Sambo, MMT Hosokawa, V Stahl, LGR Lima, B Stefanello, LW Santos, SS Medina, MP Colella, SAL Montalvão, GG Yamaguti-Hayakawa, MC Ozelo

Publikováno v: Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S559-S560 (2024)

Background: Hemophilia A (HA) treatment primarily involves factor VIII (FVIII) replacement therapy, but the development of inhibitors hampers management and leads to increased morbidity and mortality. Immune tolerance induction (ITI) is employed to r

Externí odkaz: https://doaj.org/article/ae9fd183a51c47628c9dbe07af04f442

Circulating levels of the angiogenesis mediators endoglin, HB-EGF, BMP-9 and FGF-2 in patients with severe sepsis and septic shock.

Autor: Faiotto VB; School of Medical Sciences, University of Campinas, Campinas, SP, Brazil., Franci D; School of Medical Sciences, University of Campinas, Campinas, SP, Brazil., Enz Hubert RM; School of Medical Sciences, University of Campinas, Campinas, SP, Brazil., de Souza GR; School of Medical Sciences, University of Campinas, Campinas, SP, Brazil., Fiusa MML; School of Medical Sciences, University of Campinas, Campinas, SP, Brazil., Hounkpe BW; School of Medical Sciences, University of Campinas, Campinas, SP, Brazil., Santos TM; School of Medical Sciences, University of Campinas, Campinas, SP, Brazil., Carvalho-Filho MA; School of Medical Sciences, University of Campinas, Campinas, SP, Brazil., De Paula EV; School of Medical Sciences, University of Campinas, Campinas, SP, Brazil; Hematology and Hemotherapy Center, University of Campinas, Campinas, SP, Brazil. Electronic address: erich@unicamp.br.

Publikováno v: Journal of critical care [J Crit Care] 2017 Dec; Vol. 42, pp. 162-167. Date of Electronic Publication: 2017 Jul 17.